These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2033431)
1. Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases. Dini G; Lanino E; Garaventa A; Rogers D; Dallorso S; Viscoli C; Castagnola E; Manno G; Brisigotti M; Rosanda C J Clin Oncol; 1991 Jun; 9(6):962-9. PubMed ID: 2033431 [TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation. McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740 [TBL] [Abstract][Full Text] [Related]
3. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age. Philip T; Bernard JL; Zucker JM; Pinkerton R; Lutz P; Bordigoni P; Plouvier E; Robert A; Carton R; Philippe N J Clin Oncol; 1987 Feb; 5(2):266-71. PubMed ID: 3543245 [TBL] [Abstract][Full Text] [Related]
4. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group. Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005 [TBL] [Abstract][Full Text] [Related]
5. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma. Kushner BH; Gulati SC; Kwon JH; O'Reilly RJ; Exelby PR; Cheung NK Cancer; 1991 Jul; 68(2):242-7. PubMed ID: 1906368 [TBL] [Abstract][Full Text] [Related]
6. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111 [TBL] [Abstract][Full Text] [Related]
7. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417 [TBL] [Abstract][Full Text] [Related]
8. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma]. Dini G; Garaventa A; Lanino E; Perin GP; Scarpati D; Viscoli C; Franchini E; Corvò R; Dallorso S; Cinollo G Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621 [TBL] [Abstract][Full Text] [Related]
9. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma. Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093 [TBL] [Abstract][Full Text] [Related]
10. [High-dose chemoradiotherapy with bone marrow transplantation as a consolidation treatment of neuroblastoma. Results in 49 unselected patients with stage IV cancer and older than 1 year. Report of the LMCE neuroblastoma group]. Kremens B; Philip T; Bernard JL; Zucker JM Klin Padiatr; 1987; 199(3):218-23. PubMed ID: 3306132 [TBL] [Abstract][Full Text] [Related]
11. Chemo-radiotherapy and autologous bone marrow transplantation in poor prognosis neuroblastoma. Franzone P; Scarpati D; Vitale V; Corvó R; Barra S; Guenzi M; Orsatti M; Dini G Radiother Oncol; 1990; 18 Suppl 1():102-4. PubMed ID: 2247630 [TBL] [Abstract][Full Text] [Related]
12. [Intensive chemotherapy and bone marrow grafting during the consolidation phase of stage IV neuroblastoma]. Philip T; Zucker JM; Bernard JL; Bordigoni P; Souillet G; Robert A; Roche H; Philip I; Chauvin F; Favrot MC Bull Cancer; 1988; 75(1):113-7. PubMed ID: 3282573 [TBL] [Abstract][Full Text] [Related]
13. Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study. Matthay KK; Atkinson JB; Stram DO; Selch M; Reynolds CP; Seeger RC J Clin Oncol; 1993 Nov; 11(11):2226-33. PubMed ID: 8229138 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group. Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954 [TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. Ladenstein R; Philip T; Lasset C; Hartmann O; Garaventa A; Pinkerton R; Michon J; Pritchard J; Klingebiel T; Kremens B; Pearson A; Coze C; Paolucci P; Frappaz D; Gadner H; Chauvin F J Clin Oncol; 1998 Mar; 16(3):953-65. PubMed ID: 9508178 [TBL] [Abstract][Full Text] [Related]
16. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319 [TBL] [Abstract][Full Text] [Related]
17. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study. Pole JG; Casper J; Elfenbein G; Gee A; Gross S; Janssen W; Koch P; Marcus R; Pick T; Shuster J J Clin Oncol; 1991 Jan; 9(1):152-8. PubMed ID: 1985165 [TBL] [Abstract][Full Text] [Related]
18. Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group. Bonetti F; Zecca M; Pession A; Messina C; Montagna D; Lanino E; Fagioli F; Santoro N; Prete A; Cesaro S; Rondelli R; Giorgiani G; De Stefano P; Locatelli F J Clin Oncol; 1999 Dec; 17(12):3729-35. PubMed ID: 10577844 [TBL] [Abstract][Full Text] [Related]
19. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717 [TBL] [Abstract][Full Text] [Related]
20. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]